NEW YORK (GenomeWeb) — GenMark Diagnostics reported after the close of the market on Thursday that its second quarter revenues rose 37 percent year over year.

For the three months ended Sept. 30, the company reported $6.3 million in revenues, up from $4.6 million for the third quarter of 2013, and above the average analyst estimate of $5.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.